当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:176.29亿  总市值:181.21亿
流通股本:15.56亿   总股本:15.99亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.07亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1076629.82万元,未分配利润305617.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1400250.18万元,负债323620.36万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,154,212,387462,257,650.832,821,441,302.712,141,346,183.01
营业总成本975,738,044.24426,650,521.542,531,774,103.411,756,031,473.68
其他经营收益
营业利润13,928,276.59-13,576,069.5296,674,057.99286,082,966.34
利润总额12,042,491.96-14,770,200.32184,502,101.62373,789,190.09
净利润-7,094,241.99-19,682,659.04174,397,875.24350,640,884.9
每股收益
其他综合收益39,950,000--45,900,000-
综合收益总额32,855,758.01-19,682,659.04128,497,875.24350,640,884.9
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计6,727,743,135.546,748,867,229.37,066,828,580.517,397,846,398.35
非流动资产:
非流动资产合计7,274,758,697.417,615,216,822.157,657,483,328.747,605,862,604.54
资产总计14,002,501,832.9514,364,084,051.4514,724,311,909.2515,003,709,002.89
流动负债:
流动负债合计2,388,098,966.112,061,239,206.082,370,002,301.992,389,955,735.47
非流动负债:
非流动负债合计848,104,682.44814,663,092.61846,445,195.46883,745,845.96
负债合计3,236,203,648.552,875,902,298.693,216,447,497.453,273,701,581.43
所有者权益(或股东权益):
归属于母公司股东权益合计9,496,660,286.669,432,189,382.259,429,543,133.679,589,641,343.38
股东权益合计10,766,298,184.411,488,181,752.7611,507,864,411.811,730,007,421.46
负债和股东权益合计14,002,501,832.9514,364,084,051.4514,724,311,909.2515,003,709,002.89
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,193,669,127.43461,359,189.823,597,730,735.82,578,934,372.58
经营活动现金流出小计1,077,012,043.08623,034,112.662,561,206,208.32,019,529,731.21
经营活动产生的现金流量净额116,657,084.35-161,674,922.841,036,524,527.5559,404,641.37
投资活动产生的现金流量:
投资活动现金流入小计191,389827,6245,362,807.514,874,532.22
投资活动现金流出小计141,478,824.7170,445,611.451,272,029,878.51,177,299,885.81
投资活动产生的现金流量净额-141,287,435.71-69,617,987.45-1,266,667,070.99-1,172,425,353.59
筹资活动产生的现金流量:
筹资活动现金流入小计2,440,000-38,399,016.1538,399,016.15
筹资活动现金流出小计1,204,374,595.6427,352,521.09409,429,658.57156,366,612.13
筹资活动产生的现金流量净额-1,201,934,595.64-27,352,521.09-371,030,642.42-117,967,595.98
汇率变动对现金及现金等价物的影响1,233,445.5419,876.895,413,290.34-5,461,839.45
现金及现金等价物净增加额-1,225,331,501.46-258,625,554.49-595,759,895.57-736,450,147.65
期末现金及现金等价物余额2,533,771,314.553,500,477,261.523,759,102,816.013,618,412,563.93
补充资料:
现金及现金等价物的净增加额-1,225,331,501.46--595,759,895.57-
TOP↑